Annual CAPEX
N/A
December 31, 2023
Summary
- APVO annual capital expenditures is not available.
Performance
APVO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- APVO quarterly capital expenditures is not available.
Performance
APVO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- APVO TTM capital expenditures is not available.
Performance
APVO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
APVO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APVO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Aptevo Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $29.00 K(-95.9%) | - | - |
| Dec 2021 | $713.00 K(+710.2%) | $118.00 K(+807.7%) | $713.00 K(+19.8%) |
| Sep 2021 | - | $13.00 K(-96.7%) | $595.00 K(+2.2%) |
| Jun 2021 | - | $391.00 K(+104.7%) | $582.00 K(+204.7%) |
| Mar 2021 | - | $191.00 K(>+9900.0%) | $191.00 K(+24.8%) |
| Dec 2020 | $88.00 K(-42.5%) | - | - |
| Dec 2019 | $153.00 K(-84.3%) | $0.00(0.0%) | $153.00 K(-24.3%) |
| Sep 2019 | - | $0.00(0.0%) | $202.00 K(-64.1%) |
| Jun 2019 | - | $0.00(-100.0%) | $562.00 K(-14.3%) |
| Mar 2019 | - | $153.00 K(+212.2%) | $656.00 K(-32.8%) |
| Dec 2018 | $976.00 K(-30.4%) | $49.00 K(-86.4%) | $976.00 K(-20.3%) |
| Sep 2018 | - | $360.00 K(+283.0%) | $1.22 M(+22.5%) |
| Jun 2018 | - | $94.00 K(-80.1%) | $999.00 K(-7.6%) |
| Mar 2018 | - | $473.00 K(+59.3%) | $1.08 M(-22.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $1.40 M(-44.2%) | $297.00 K(+120.0%) | $1.40 M(-16.7%) |
| Sep 2017 | - | $135.00 K(-23.3%) | $1.68 M(+12.0%) |
| Jun 2017 | - | $176.00 K(-77.8%) | $1.50 M(-32.8%) |
| Mar 2017 | - | $794.00 K(+37.1%) | $2.23 M(-11.0%) |
| Dec 2016 | $2.51 M(+64.5%) | $579.00 K(-1358.7%) | $2.51 M(+2.6%) |
| Sep 2016 | - | -$46.00 K(-105.1%) | $2.45 M(-16.5%) |
| Jun 2016 | - | $908.00 K(-15.2%) | $2.93 M(+19.3%) |
| Mar 2016 | - | $1.07 M(+108.0%) | $2.46 M(+60.9%) |
| Dec 2015 | $1.53 M(+54.4%) | $515.00 K(+17.6%) | $1.53 M(+50.9%) |
| Sep 2015 | - | $438.00 K(+1.2%) | $1.01 M(+76.3%) |
| Jun 2015 | - | $433.00 K(+207.1%) | $574.00 K(+307.1%) |
| Mar 2015 | - | $141.00 K | $141.00 K |
| Dec 2014 | $989.00 K(-3.1%) | - | - |
| Dec 2013 | $1.02 M | - | - |
FAQ
- What is the all time high annual CAPEX for Aptevo Therapeutics?
- What is the all time high quarterly CAPEX for Aptevo Therapeutics?
- What is the all time high TTM CAPEX for Aptevo Therapeutics?
What is the all time high annual CAPEX for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual capital expenditures is $2.51 M
What is the all time high quarterly CAPEX for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly capital expenditures is $1.07 M
What is the all time high TTM CAPEX for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM capital expenditures is $2.93 M